Home LiteratureArticle Details
PMID: 17122049 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth.

Cafferty WB, Strittmatter SM

Abstract

The hypothesis that Nogo-A (Reticulon 4A) and Nogo-66 receptor (NgR1) limit adult CNS axonal growth after injury is supported by both in vitro experiments and in vivo pharmacological studies. However, genetic assessment of the role of Nogo-A in corticospinal tract (CST) axons after spinal cord dorsal hemisection has yielded conflicting results. CST regeneration is detected in homozygous nogo-ab(trap/trap) mice, but not in nogo-ab(atg/atg) mice. CST regeneration is also present after pharmacological NgR blockade, but not in ngr1(-/-) mice. To assess the nogo-ab(atg) and ngr1-null alleles for other axon growth phenotypes, we created unilateral pyramidotomies and monitored the uninjured CST. There is robust pyramidotomy-induced growth of nogo-ab(atg/atg) and ngr1(-/-) CST axons into denervated cervical gray matter. This fiber growth correlates with recovery of fine motor skill in the affected forelimb. Thus nogo-ab and ngr1 play a modulated role in limiting CNS axonal growth across a spectrum of different tracts in various lesion models.

MeSH Terms
Analysis of Variance Animals Axons/physiology Behavior, Animal Calcitonin Gene-Related Peptide/metabolism Central Nervous System/cytology Functional Laterality Glial Fibrillary Acidic Protein/metabolism Mice Mice, Inbred C57BL Mice, Knockout Myelin Basic Protein/metabolism Myelin Proteins/metabolism Nogo Proteins Protein Kinase C/metabolism Psychomotor Performance/physiology Pyramidal Tracts/injuries,metabolism,physiology Receptors, Peptide/deficiency,metabolism Signal Transduction/physiology
Chemicals
Glial Fibrillary Acidic Protein Myelin Basic Protein Myelin Proteins Nogo Proteins Receptors, Peptide Rtn4 protein, mouse protein kinase C gamma Protein Kinase C Calcitonin Gene-Related Peptide
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cafferty William B J
Program in Cellular Neuroscience, Neurodegeneration, and Repair, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Strittmatter Stephen M
References (43)
43 references, click to expand
  1. Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration.
    J Neurosci. 2006 May 24;26(21):5591-603 PMID: 16723516
  2. Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells.
    Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10997-1002 PMID: 16835300
  3. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions.
    Nat Neurosci. 1998 Jun;1(2):124-31 PMID: 10195127
  4. Inosine stimulates extensive axon collateral growth in the rat corticospinal tract after injury.
    Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13486-90 PMID: 10557347
  5. Inhibitor of neurite outgrowth in humans.
    Nature. 2000 Jan 27;403(6768):383-4 PMID: 10667780
  6. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
    Nature. 2000 Jan 27;403(6768):434-9 PMID: 10667796
  7. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein.
    Nature. 2000 Jan 27;403(6768):439-44 PMID: 10667797
  8. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration.
    Nature. 2001 Jan 18;409(6818):341-6 PMID: 11201742
  9. Lack of enhanced spinal regeneration in Nogo-deficient mice.
    Neuron. 2003 Apr 24;38(2):213-24 PMID: 12718856
  10. Motor cortex organization after stroke is related to side of stroke and level of recovery.
    Stroke. 2003 May;34(5):e23-8 PMID: 12677024
  11. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
    J Neurosci. 2003 May 15;23(10):4219-27 PMID: 12764110
  12. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins.
    EMBO J. 2003 Jul 1;22(13):3291-302 PMID: 12839991
  13. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions.
    J Neurosci. 2003 Jul 2;23(13):5393-406 PMID: 12843238
  14. Motor representation in patients rapidly recovering after stroke: a functional magnetic resonance imaging and transcranial magnetic stimulation study.
    Clin Neurophysiol. 2003 Dec;114(12):2404-15 PMID: 14652101
  15. A new role for Nogo as a regulator of vascular remodeling.
    Nat Med. 2004 Apr;10(4):382-8 PMID: 15034570
  16. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity.
    J Neurosci. 2004 Jul 7;24(27):6209-17 PMID: 15240813
  17. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Neuron. 2004 Oct 28;44(3):439-51 PMID: 15504325
  18. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats.
    Science. 1981 Nov 20;214(4523):931-3 PMID: 6171034
  19. Extensive elongation of axons from rat brain into peripheral nerve grafts.
    Nature. 1982 Mar 11;296(5853):150-2 PMID: 7063015
  20. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors.
    Nature. 1990 Jan 18;343(6255):269-72 PMID: 2300171
  21. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration.
    Neuron. 1994 Sep;13(3):757-67 PMID: 7522484
  22. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth.
    Neuron. 1994 Oct;13(4):805-11 PMID: 7524558
  23. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors.
    Nature. 1995 Nov 30;378(6556):498-501 PMID: 7477407
  24. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
    J Neurosci. 2004 Nov 17;24(46):10511-20 PMID: 15548666
  25. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1205-10 PMID: 15647357
  26. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.
    J Neurosci. 2005 Jan 26;25(4):808-22 PMID: 15673660
  27. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types.
    J Biol Chem. 2005 Apr 1;280(13):12494-502 PMID: 15640160
  28. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist.
    J Neurosci. 2005 Jun 1;25(22):5298-304 PMID: 15930377
  29. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth.
    Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10694-9 PMID: 16020529
  30. Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice.
    Exp Neurol. 2005 Oct;195(2):524-39 PMID: 16051217
  31. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats.
    J Cereb Blood Flow Metab. 2005 Oct;25(10):1366-75 PMID: 15889044
  32. A class of membrane proteins shaping the tubular endoplasmic reticulum.
    Cell. 2006 Feb 10;124(3):573-86 PMID: 16469703
  33. Functional MRI detects posterior shifts in primary sensorimotor cortex activation after stroke: evidence of local adaptive reorganization?
    Stroke. 2001 May;32(5):1134-9 PMID: 11340222
  34. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat.
    Ann Neurol. 2002 Apr;51(4):433-41 PMID: 11921049
  35. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    Nature. 2002 May 30;417(6888):547-51 PMID: 12037567
  36. Longitudinal study of motor recovery after stroke: recruitment and focusing of brain activation.
    Stroke. 2002 Jun;33(6):1610-7 PMID: 12053000
  37. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Nature. 2002 Jun 27;417(6892):941-4 PMID: 12068310
  38. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact.
    J Neurosci. 2002 Jul 1;22(13):5505-15 PMID: 12097502
  39. Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord.
    J Neurosci. 2002 Aug 15;22(16):7097-110 PMID: 12177206
  40. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor.
    Science. 2002 Aug 16;297(5584):1190-3 PMID: 12089450
  41. No Nogo: now where to go?
    Neuron. 2003 Apr 24;38(2):153-6 PMID: 12718850
  42. Axon regeneration in young adult mice lacking Nogo-A/B.
    Neuron. 2003 Apr 24;38(2):187-99 PMID: 12718854
  43. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury.
    Neuron. 2003 Apr 24;38(2):201-11 PMID: 12718855
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2006-11-22
Pages
12242-50
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC2848954
Subset
IM
Grants
NINDS NIH HHS · R01 NS042304-09 · United States
NINDS NIH HHS · R37 NS033020 · United States
NINDS NIH HHS · R01 NS056485 · United States
NINDS NIH HHS · R01 NS039962-10 · United States
NINDS NIH HHS · R01 NS042304 · United States
NINDS NIH HHS · R37 NS033020-17 · United States
NINDS NIH HHS · R01 NS056485-05 · United States
NINDS NIH HHS · R01 NS039962 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com